Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR1 | P30989 | 19/20 | 0.72 |
| ▸ | NTSR2 | O95665 | 17/20 | 0.72 |
| ▸ | SORT1 | Q99523 | 17/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30038817 | 0.92 | NTSR1 (0.63) | NTSR1NTSR2SORT1 | |
| SCHEMBL29886800 | 0.90 | NTSR2 (0.67) | NTSR1NTSR2SORT1 | |
| SCHEMBL30864885 | 0.89 | NTSR1 (0.78) | NTSR1NTSR2SORT1 | |
| SCHEMBL30038534 | 0.89 | NTSR1 (0.60) | NTSR1NTSR2SORT1 | |
| SCHEMBL19682065 | 0.89 | NTSR1 (0.58) | NTSR1NTSR2SORT1 | |
| SCHEMBL12523184 | 0.89 | NTSR1 (0.60) | NTSR1NTSR2SORT1 | |
| SCHEMBL12523185 | 0.88 | NTSR1 (0.58) | NTSR1NTSR2SORT1 | |
| SCHEMBL32664435 | 0.87 | NTSR2 (0.58) | NTSR1NTSR2SORT1 | |
| SCHEMBL30943511 | 0.87 | NMUR2 (0.58) | NTSR1NTSR2SORT1 | |
| SCHEMBL19682203 | 0.86 | NTSR1 (0.56) | NTSR1NTSR2SORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250276100-A1 | DEVELOPMENT OF NTSR TARGETED AGENTS FOR IMAGING AND THERAPY APPLICATIONS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2025-09-04 | — | — | US | disclosed |
| EP-4518912-A1 | DEVELOPMENT OF NTSR TARGETED AGENTS FOR IMAGING AND THERAPY APPLICATIONS | The University of North Carolina at Chapel Hill (US) | 2025-03-12 | — | — | EP | disclosed |
| CN-119325393-A | Development of agents targeting NTSR for imaging and therapeutic applications | 北卡罗来纳大学教堂山分校 | 2025-01-17 | — | — | CN | disclosed |
| WO-2023215778-A1 | DEVELOPMENT OF NTSR TARGETED AGENTS FOR IMAGING AND THERAPY APPLICATIONS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2023-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250276100-A1 | DEVELOPMENT OF NTSR TARGETED AGENTS FOR IMAGING AND THERAPY APPLICATIONS | NTSR1, NTSR2, NPSR1 | NTSR1 1/4885NTSR2 2/4885SORT1 161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.